Author:
Hwang S.-L.,Liu I.-M.,Tzeng T.-F.,Cheng J.-T.
Publisher
Springer Science and Business Media LLC
Subject
Endocrinology, Diabetes and Metabolism,Internal Medicine
Reference36 articles.
1. Reid JL, Panfilov V, MacPhee G, Elliott HL (1995) Clinical pharmacology of drugs acting on imidazoline and adrenergic receptors. Studies with clonidine, moxonidine, rilmenidine, and atenolol. Ann NY Acad Sci 763:673?678
2. Michel MC, Insel PA (1989) Are there multiple imidazoline binding sites? Trends Pharmacol Sci 10:342?344
3. Michel MC, Ernsberger P (1992) Keeping an eye on the I site: imidazoline-preferring receptors. Trends Pharmacol Sci 13:369?370
4. Raasch W, Schafer U, Chun J, Dominiak P (2001) Biological significance of agmatine, an endogenous ligand at imidazoline binding sites. Br J Pharmacol 133:755?780
5. Schulz A, Hasselblatt A (1989) An insulin-releasing property of imidazoline derivatives is not limited to compounds that block alpha-adrenoceptors. Naunyn-Schmiedeberg?s Arch Pharmacol 340:321?327
Cited by
49 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献